BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16808839)

  • 1. Dyspnea assessment and adverse events during sputum induction in COPD.
    Makris D; Tzanakis N; Moschandreas J; Siafakas NM
    BMC Pulm Med; 2006 Jun; 6():17. PubMed ID: 16808839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety of sputum induction in adults with acute exacerbation of COPD.
    Gao P; Gibson PG; Zhang J; He X; Hao Y; Li P; Liu H
    Clin Respir J; 2013 Jan; 7(1):101-9. PubMed ID: 22452898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
    Kömüs N; Tertemiz KC; Sevinç C
    Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Airway response to inhaled hypertonic saline in patients with moderate to severe chronic obstructive pulmonary disease.
    Taube C; Holz O; Mücke M; Jörres RA; Magnussen H
    Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 1):1810-5. PubMed ID: 11734428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different COPD disease characteristics are related to different outcomes in the 6-minute walk test.
    Waatevik M; Johannessen A; Hardie JA; Bjordal JM; Aukrust P; Bakke PS; Eagan TM
    COPD; 2012 Jun; 9(3):227-34. PubMed ID: 22497532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of sputum induction in moderate-to-severe chronic obstructive pulmonary disease.
    Sutherland ER; Pak J; Langmack EL; Silkoff PE; Martin RJ
    Respir Med; 2002 Jul; 96(7):482-6. PubMed ID: 12194630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [How can we assess the perception of induced dyspnea in chronic obstructive pulmonary disease?].
    Martínez Francés ME; Perpiñá Tordera M; Belloch Fuster A; Martínez Moragón EM; de Diego Damiá A
    Arch Bronconeumol; 2004 Apr; 40(4):149-54. PubMed ID: 15030728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of inducing sputum in patients with asthma of varying severity.
    de la Fuente PT; Romagnoli M; Godard P; Bousquet J; Chanez P
    Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1127-30. PubMed ID: 9563729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of respiratory symptoms in persons with restrictive ventilatory impairment compared with persons with chronic obstructive pulmonary disease: The PLATINO study.
    Nonato NL; Nascimento OA; Padilla RP; de Oca MM; Tálamo C; Valdivia G; Lisboa C; López MV; Celli B; Menezes AM; Jardim JR
    Chron Respir Dis; 2015 Aug; 12(3):264-73. PubMed ID: 26041119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of sputum induction during exacerbations of COPD.
    Bathoorn E; Liesker J; Postma D; Koëter G; van Oosterhout AJ; Kerstjens HA
    Chest; 2007 Feb; 131(2):432-8. PubMed ID: 17296644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Sit-to-Stand Test with 6 min walk test in patients with chronic obstructive pulmonary disease.
    Ozalevli S; Ozden A; Itil O; Akkoclu A
    Respir Med; 2007 Feb; 101(2):286-93. PubMed ID: 16806873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between hypertonic and isotonic saline-induced sputum in the evaluation of airway inflammation in subjects with moderate asthma.
    Bacci E; Cianchetti S; Paggiaro PL; Carnevali S; Bancalari L; Dente FL; Di Franco A; Giannini D; Vagaggini B; Giuntini C
    Clin Exp Allergy; 1996 Dec; 26(12):1395-400. PubMed ID: 9027440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of walk distance, work, oxygen saturation, and dyspnea during 6-minute walk test in COPD patients.
    Golpe R; Pérez-de-Llano LA; Méndez-Marote L; Veres-Racamonde A
    Respir Care; 2013 Aug; 58(8):1329-34. PubMed ID: 23322886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between 6-minute walk test and pulmonary function test in stable chronic obstructive pulmonary disease with different severities.
    Chen H; Liang BM; Tang YJ; Xu ZB; Wang K; Yi Q; Ou XM; Feng YL
    Chin Med J (Engl); 2012 Sep; 125(17):3053-8. PubMed ID: 22932179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional capacity in severe chronic obstructive pulmonary disease.
    Inal-Ince D; Savci S; Coplu L; Arikan H
    Saudi Med J; 2005 Jan; 26(1):84-9. PubMed ID: 15756359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative 15 steps exercise oximetry as a marker of disease severity in patients with chronic obstructive pulmonary disease.
    Kramer MR; Krivoruk V; Lebzelter J; Liani M; Fink G
    Isr Med Assoc J; 1999 Nov; 1(3):165-8. PubMed ID: 10731326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Safety of sputum induction in interstitial lung disease].
    Sobiecka M; Kuś J
    Pneumonol Alergol Pol; 2008; 76(1):11-8. PubMed ID: 18283650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease.
    Ofir D; Laveneziana P; Webb KA; Lam YM; O'Donnell DE
    Am J Respir Crit Care Med; 2008 Mar; 177(6):622-9. PubMed ID: 18006885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and safety of hypertonic saline inhalation combined with exercise training in patients with chronic obstructive pulmonary disease: a randomized trial.
    Valderramas SR; Atallah AN
    Respir Care; 2009 Mar; 54(3):327-33. PubMed ID: 19245725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise in severe COPD: is walking different from stair-climbing?
    Dreher M; Walterspacher S; Sonntag F; Prettin S; Kabitz HJ; Windisch W
    Respir Med; 2008 Jun; 102(6):912-8. PubMed ID: 18280129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.